Hemas posts another strong quarter with Group operating profit at Rs 1 3 billion island.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from island.lk Daily Mail and Mail on Sunday newspapers.
Hemas Ends Financial Year with a Strong Performance
May, 22, 2021
Chief Executive Officer’s Review
Hemas Holdings PLC (HHL) placed on record a resilient performance by delivering another strong quarter. Home and Personal Care (HPC) and Learning segment represented by Atlas along with Healthcare were the significant contributors to the robust performance.
HHL recorded a Group revenue of Rs.16.6 billion for the quarter ended March 31, 2021, an increase of 18.3 per cent over corresponding period last year. Group operating profit for the quarter under review at Rs.1.3 billion is a growth of 58.8 per cent over Rs.829.7 million recorded last year whilst the Group earnings of Rs.859.8 million is an increase of 79.2 per cent over last year.
Sheridan Woman Changes Plea on Drug Distribution Charges
Last fall, 30-year-old Meagan Crone was arrested and charged with three felonies- Conspiracy to Deliver a Controlled Substance to a Minor- Marijuana, Delivery of a Controlled Substance to a Juvenile- Marijuana, and Possession With Intent to Deliver a Controlled Substance- Marijuana. The crimes occurred between October 3rd and 4th of last year and involved Crone selling Marijuana to a 16-year-old individual. Two co-defendants, Michael Schutt and Donald Brower were also arrested and charged with similar crimes.
Crone, pursuant to terms of a plea agreement reached with the State, pleaded guilty to the conspiracy and delivery charges at a hearing in District Court Tuesday. The state is recommending that the possession charge be dismissed as part of the plea deal. District Court Judge John Fenn told Crone that the Court is by no means bound by the terms of the plea agreement, and may reject the plea deal altogether at sentencing.
Share this article
Share this article
DUBLIN, Ohio, May 6, 2021 /PRNewswire/ Cardinal Health (NYSE: CAH) today reported third-quarter fiscal year 2021 revenue of $39.3 billion, in-line with the third quarter of last year. Third-quarter GAAP operating earnings decreased 16% to $473 million, primarily due to the write-down of the net assets held for sale from the planned divestiture of the Cordis business. Third-quarter GAAP diluted earnings per share (EPS) decreased to $0.40, due to the previously-disclosed tax effect of the litigation charge in the first quarter.
Non-GAAP operating earnings decreased 4% to $689 million in the quarter due to the negative impact from COVID-19, primarily concentrated in the Pharmaceutical segment. Non-GAAP diluted EPS decreased 6% to $1.53 in the quarter, reflecting a higher non-GAAP effective tax rate, partially offset by lower interest expense.
Operator
Good day, and welcome to the Cardinal Health, Inc. Third Quarter Fiscal Year 2021 Earnings Conference Call. [Operator Instructions]
At this time, I would like to turn the conference over to Kevin Moran, Vice President of Investor Relations. Please go ahead.
Kevin Moran
Vice President of Investor Relations
Good morning, and welcome. Today, we will discuss Cardinal Health s third quarter fiscal 2021 results, along with an update to our FY 21 outlook. You can find today s press release and presentation on the IR section of our website at ir.cardinalhealth.com. Joining me today are Mike Kaufmann, Chief Executive Officer; and Jason Hollar, Chief Financial Officer. During the call, we will be making forward-looking statements. The matters addressed in the statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide at the b